We use cookies for a better user experience. Read our Privacy Policy

I Agree

Aarskog Syndrome Treatment Market

Aarskog Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Aarskog Syndrome Treatment Market: Introduction

  • Aarskog syndrome is a rare genetic condition caused primarily due to a specific gene mutation, leading to short stature and multiple facial and other limb & genital abnormalities. Aarskog syndrome majorly affects the male population and its clinical symptoms can be different in affected individuals.
  • People suffering from Aarskog syndrome appear to have rounded face with broad forehead. Other symptoms include ocular hypertelorism, dropping of eyelids, palpebral fissures, anteverted nares, and underdeveloped upper jawbone.
  • As per research, FGD1 gene mutation is the major cause of Aarskog syndrome; however, there could be unidentified genes that may be linked with the Aarskog condition
  • Aarskog syndrome is a genetic disorder; hence, it generally affects the height, genitals, face, and hands of the affected individuals. Moreover, diagnosis of the Aarskog syndrome is usually done with the facial features and is confirmed by genetic testing.
  • There is no exact cure for Aarskog syndrome; however, available medications help ease the symptoms and related eye, ear, or dental issues. Additionally, in some cases, surgery is required for inguinal hernia, cleft lip or palate, and/or undescended testicles condition.

Key Drivers, Restraints, and Opportunities of Aarskog Syndrome Treatment Market

  • Ongoing clinical trials, increasing prevalence & incidence of Aarskog syndrome, and technological advancements are a few factors that are projected to boost the global market
  • Prevalence of Aarskog syndrome is estimated to be around 1 per 25,000 population. This is likely to propel the Aarskog syndrome treatment market globally in the near future.
  • Benefits of growth hormones in patients suffering from Aarskog Syndrome are anticipated to also boost its awareness and enhance adoption among physicians/patients. These are a few other factors that are likely to boost the Aarskog syndrome treatment market.
  • Moreover, adoption of surgeries for treatment of various orthodontic issues and eye defects is a key factor that is expected to boost the demand for accurate management or treatment of this condition
  • However, delay in diagnosis of this rare disease, lack of awareness, and limited evidence are few factors that are projected to restrain the Aarskog syndrome treatment market

North America to dominate global Aarskog Syndrome Treatment market

  • North America is expected to hold a prominent market share owing to the high diagnosis rate of the disease, awareness about the disease, and increased number of clinical studies/trials in the region. These are key factors that are likely to drive the market in the region during the forecast period. Moreover, several organizations, foundations and patient support groups in the region are focused on creating awareness about the disease and are engages in supporting the people suffering from Aarskog syndrome.
  • Europe is also expected to hold a major share in the global Aarskog syndrome treatment market due to rising awareness about Aarskog syndrome and a rise in the number of clinical studies/trials in the region. Furthermore, differential diagnosis, antenatal diagnosis, genetic counselling, etc., are a few diagnostic tools that are anticipated to further propel the market in the region in the near future.

Key Companies of Aarskog Syndrome Treatment Market

  • VECTOR BIOLABS
  • Santa Cruz Biotechnology, Inc
  • MyBiosource, Inc.
  • Pfizer
  • Novo Nordisk
  • Eli Lilly and Company
  • Genescience pharmaceuticals
  • Johnson & Johnson Private Limited
  • Medtronic

Aarskog Syndrome Treatment Market, Research Scope

Aarskog Syndrome Treatment Market, by Type

  • Facial
  • Limb
  • Genital
  • Others

Aarskog Syndrome Treatment Market, by Treatment

  • Growth hormone therapy
  • Inguinal hernia repair surgery
  • Cryptorchidism surgery
  • Cleft lip or palate surgery
  • Strabismus treatment
  • Nystagmus treatment
  • Auxiliary treatment

Aarskog Syndrome Treatment Market, by End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Aarskog Syndrome Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Aarskog Syndrome Treatment Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

427

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved